Skip to main content
Fig. 4 | Cell & Bioscience

Fig. 4

From: Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids

Fig. 4

Spheroid toxicity analysis of NP-Tal at varying doses. Spheroids composed of OVCAR8-DsRed2 cells and NCI/ADR-RES-EGFP cells were treated with NP-Tal at varying doses 3 days after seeding. Fluorescence was recorded up to 12 days, and intensity values for each cell line were normalized to the untreated spheroids to calculate cell viability. Longitudinal viability for parental and subline cells are shown from days 1–12 for NP-Tal doses at 0.01 μM (a), 0.04 μM (b), 0.11 μM (c), 0.33 μM (d) 1 μM (e), and 3 μM (f). Representative images of spheroids on day 12 at each treatment dose are shown (g). Scale bar = 1000 μm. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001; **** p ≤ 0.0001

Back to article page